VITROS 6802156Recalls & reported problems
Ortho Clinical Diagnostics · VITROS Immunodiagnostic Products NT proBNP Reagent Pack · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10758750002061), received between Aug 17, 2023 and Oct 11, 2023 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results3
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 11, 2023Low Test Results; Low Test Results
A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT LOWER THAN EXPECTED NT ¿ PROBNP II (NTBNP II) RESULTS WERE OBTAINED WHEN PROCESSING A NON-VITROS MAS CARDIO-IMMUNE QUALITY CONTROL (QC) FLUID LOT OIM2503 ON A VITROS 5600 INTEGRATED SYSTEM. MAS QC LEVEL 2 RESULTS OF 307, 310.32, 312.70, 317.51 AND 320.22 PG/ML VS EXPECTED RESULT OF 428 PG/ML. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE LOWER THAN EXPECTED VITROS NTBNP II RESULTS WERE OBTAINED WHEN PROCESSING NON-PATIENT FLUID. THE CUSTOMER MADE NO INDICATION THAT ANY PATIENT SAMPLE RESULTS HAD BEEN AFFECTED. THERE WERE NO REPORTED ALLEGATIONS OF HARM AS A RESULT OF THIS EVENT. THIS REPORT IS NUMBER TWO OF TWO MDR¿S FOR THIS EVENT. TWO 3500A FORMS ARE BEING SUBMITTED FOR THIS EVENT AS TWO DEVICES WERE INVOLVED. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17916053 ↗MalfunctionOct 11, 2023Low Test Results; Low Test Results
A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT LOWER THAN EXPECTED NT ¿ PROBNP II (NTBNP II) RESULTS WERE OBTAINED WHEN PROCESSING A NON-VITROS MAS CARDIO-IMMUNE QUALITY CONTROL (QC) FLUID LOT OIM2503 ON A VITROS 5600 INTEGRATED SYSTEM. MAS QC LEVEL 2 RESULTS OF 307, 310.32, 312.70, 317.51 AND 320.22 PG/ML VS EXPECTED RESULT OF 428 PG/ML. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE LOWER THAN EXPECTED VITROS NTBNP II RESULTS WERE OBTAINED WHEN PROCESSING NON-PATIENT FLUID. THE CUSTOMER MADE NO INDICATION THAT ANY PATIENT SAMPLE RESULTS HAD BEEN AFFECTED. THERE WERE NO REPORTED ALLEGATIONS OF HARM AS A RESULT OF THIS EVENT. THIS REPORT IS NUMBER ONE OF TWO MDR¿S FOR THIS EVENT. TWO 3500A FORMS ARE BEING SUBMITTED FOR THIS EVENT AS TWO DEVICES WERE INVOLVED. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17916042 ↗MalfunctionAug 17, 2023Low Test Results; Low Test Results
A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT LOWER THAN EXPECTED NT-PROBNP II (NTBNP II) RESULTS WERE OBTAINED WHEN PROCESSING A VITROS NTBNP II RANGE VERIFIER (RV) FLUID ON A VITROS 5600 INTEGRATED SYSTEM. VITROS NPBNP II RV RESULTS OF 14642.1, 14692.7, 15523.8, 15595.2 AND 16033.2 PG/ML VS EXPECTED RESULT OF 29400 PG/ML BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE LOWER THAN EXPECTED VITROS NTBNP II RESULT WAS OBTAINED WHEN PROCESSING VITROS NTBNP II NON-PATIENT FLUID. THE CUSTOMER MADE NO INDICATION THAT ANY PATIENT SAMPLE RESULTS HAD BEEN AFFECTED. ORTHO HAS NOT BEEN MADE AWARE OF ANY ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17565319 ↗
Other TEST,NATRIURETIC PEPTIDE devices
- PATHFAST NTproBNP N/APhc Corporation · Test,Natriuretic Peptide1 recall0 reports
- VITROS 6192255Ortho Clinical Diagnostics · Test, natriuretic peptide18 reports
- Elecsys proBNP II Immunoassay 09315284190Roche Diagnostics GmbH · Test, natriuretic peptide8 reports
- Elecsys proBNP II Immunoassay 09315268160Roche Diagnostics GmbH · Test, natriuretic peptide5 reports
- i-STAT 03P93-25Abbott Point Of Care Inc. · TEST,NATRIURETIC PEPTIDE2 reports
- Access BNP 98200Beckman Coulter, Inc. · Test, Natriuretic Peptide2 reports
- Elecsys proBNP II STAT Immunoassay 09315276160Roche Diagnostics GmbH · Test, natriuretic peptide2 reports
- Elecsys ProBNP II 09744959190Roche Diagnostics GmbH · Test, natriuretic peptide1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page